Makes riskier type loans to a wide range of companies. If they don’t work out, then they take the equity in and try to fix the problem. Put themselves up for sale and were going to privatize. An independent valuation was in the $18-$20 range. There was a lawsuit. The person suing was saying bad things about the company. The stock dropped from $17-$18 down to below $10. Meanwhile the company and insiders continued to buy back and the company was saying they were still on board with the privatization process. This has a bit of a mixed view, but they continue to pay the dividend and continue to buy back stock. It has dragged on for almost a year, and investors are getting frustrated. Dividend yield of almost 12%.
He is still very confident in this. In Oct /16 they announced a privatization plan, and hired Goldman Sachs to lead the process. Had set a guidance on privatization by the end of June/17. Shortly before that, they announced privatization had been delayed, so the share price sold off. Management still expects something to occur in the fall, and still remains positive. A very good business. The underlying capacity has actually grown over the last 1-1.5 years, so when they do re-start their lending, the capacity of the company will be something that will be taken into account by potential buyers. When they announced the delay, they also announced they were exploring opportunities with private debt funds, which is something that hadn’t been taken into account. 12% dividend yield is a red flag to investors, but the leverage of the company is 25%-30%, and management feels it should be closer to 70%. They will absolutely use their balance sheet to fund the dividend, and there is no way they will cut the dividend.
When buying this kind of investment, you are betting on the individual or management team running it. Whether it is a rough quarter or a good quarter, it shouldn’t change your outlook or long-term view on the business. These kinds of structures are generally focused, and the people running them do a great deal of due diligence before investing. He wouldn’t let a bad quarter derail you from holding it long-term.
Things look pretty interesting right now. Payout ratio looks very low in the 10%-20% range. They provide financing to distressed companies. The core business is high risk, but all loans are backed by the assets of the Company they are providing financing to. They’ve had an independent valuation from National Bank (NA-T) and their price is $16-$18, and are in the process of trying to sell it right now. The sales process has been delayed so they are opening up to more potential buyers. To him, the distribution looks quite safe.
(Top Pick Jun 10’16, Up 3.42%) Last year they announced a 4 stage plan. At the end of October they announced a privatization plan, but it has been delayed. They are considering a private debt fund. Hold it if you understand the math.
It is specialty financing so they get caught up in the whole HCG-T space. CBL-T is in a corporate mess. You have to wait for the dust to settle. When there is something this acute, the chart and technical analysis are not useful.
A high-risk lender. It is down a lot and offers a dividend yield, and they’ve been buying back tons and tons of stock. If there is any downturn in the economy, some of the protection that was offered on their loans from their parent company, has now expired. He would stay away.
(A Top Pick April 26/16. Up 8%.) An asset based lender to distressed companies. They deal with companies that banks won’t touch. A controversial name and is down about 20% in the last 2 days. It is in the midst of a privatization process and had 19 expressions of interest. They’ve reduced this down to 6 or less. The guidance range as from $18-$22. Given that the stock is trading at about $14 with a 7.5%-8% yield, the privatization announcement is scheduled to take place prior to the end of June. With less than 2 months’ horizon it is a pretty good risk/return in his view. He thinks he is going to have a very happy outcome 2 months from now.
Makes very high risk loans to companies that don’t have other alternatives. Post its IPO, it has performed very poorly. They said they were investigating strategic alternatives. Feels the ultimate goal was to be selling the company with valuation in the $18-$22 range. There is a chance they could be successful. The business is very difficult and very hard to scale. They make loans to businesses that are in very far-flung industries, a reason banks don’t lend to them. Not a name he would own.
A lot of people have been buying the stock on anticipation of privatization. If it does not get bought there should be a sell off. They had 17 companies interested so he doubts the deal would not go through. He would see the company continuing to buy back stock.
They indicated taking the company private. There was an update on a press release about a week ago, where they indicated the privatization had 17 expressions of interest. The process started October 31 and the CEO thought it would be about a 6-month process, so by the end of Q2, he expects the process will be completed. Probably worth $2 over the value.
Payout ratio on 4th quarter trailing cash flow is 28%. The challenge is near term earnings which are forecast to grow significantly from $1.19 to $1.82, a 53% earnings growth forecast for 2017 gives a PE of 10X and a PE/Growth of .2 which is particularly attractive. ROE of 19% is forecasted for this year with 11% free cash flow yield. Dividend yield of 6.5%.
The CEO said 4 things to improve the share price. 1.) Initiated a dividend, 2) bought back shares, (bought back shares himself) 3) launched a substantial issuer bid, and 4) taking the company private. He has hired Goldman Sachs (GS-N) to do so. Thinks it gets taken out by at least $24, a 30% upside from here. You get a 6.5% of it in yield while waiting. Dividend yield of 6.67%. (Analysts’ price target is $19.69.)
(A Top Pick Nov 24/15. Up 80%.) Long. (A Pairs trade with a Short on Canadian Western Bank (CWB-T). This is a name that nobody liked and has traded down as low as $7 in Dec/15. It is a classic textbook example. If you are a CEO and fighting a Short Seller, you 1) deliver operationally and 2) put your money where your mouth is. In this case the CEO went out and bought shares, increased the dividend, completed a normal course issuer bid and took the extraordinary step of getting an individual evaluation of the company done. He also said if the share price did not reflect the underlying value, he was going to take the company private. Still feels the stock is extremely attractive.
Callidus Capital Corp is a Canadian stock, trading under the symbol CBL-T on the Toronto Stock Exchange (CBL-CT). It is usually referred to as TSX:CBL or CBL-T
In the last year, there was no coverage of Callidus Capital Corp published on Stockchase.
Callidus Capital Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Callidus Capital Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Callidus Capital Corp In the last year. It is a trending stock that is worth watching.
On 2019-11-08, Callidus Capital Corp (CBL-T) stock closed at a price of $0.74.
He holds a very small short position in this. Anything above 5-6% for a dividend yield suggests the dividend could be at risk, he suggests. Insiders have been buying the stock aggressively, suggesting they may be trying to take it private. It is difficult to know the value of the company due to the leverage. Yield 19.6%.